OBJECTIVES: In patients with signs and symptoms of malabsorption, suggestiv
e of gluten-sensitive enteropathy, small intestinal biopsies sometimes only
reveal infiltration of lymphocytes into the mucosal epithelium. This infil
trative lesion (Marsh I) is not a definite proof for gluten-sensitive enter
opathy. However, in the present study, we aimed to show that a subgroup of
these patients could ultimately be identified as being gluten sensitive.
METHODS: A total of 38 patients with a Marsh I lesion were subjected to a g
luten challenge comprising 30 g of gluten added daily to a normal gluten-co
ntaining diet for 8 wk. Before and after the challenge, small intestinal bi
opsies were taken, and symptoms and signs of malabsorption were scored.
RESULTS:In 12 patients we demonstrated a significant change in mucosal hist
opathology, i.e., subtotal villous atrophy (Marsh IIIB, n = 1), partial vil
lous atrophy (Marsh 3A, n = 6) or infiltrative-crypthyperplastic lesions (M
arsh II, n = 5). In the other 26 patients, the small intestinal mucosa rema
ined unchanged. After initiation of a gluten-free diet, follow-up small int
estinal biopsies in 12 patients who initially had progressive mucosal patho
logy after gluten challenge showed normalization of mucosal pathology in se
ven cases, regression to a Marsh I lesion in four, and to a Marsh n lesion
in one. Symptom relief was seen in all 12 patients. Ten of 26 patients with
out histological response to the gluten challenge were motivated to adhere
to a gluten-free diet. Follow-up biopsies revealed unchanged Marsh I lesion
s in eight patients and normalization (Marsh 0) in two patients. Three pati
ents had follow-up biopsies while on a normal diet. All had unchanged Marsh
I lesions.
CONCLUSIONS: In the present study we demonstrated that a gluten challenge m
ight be useful in identifying patients as being sensitive to gluten if init
ial small intestinal biopsies reveal only minor abnormalities. (C) 2001 by
Am. Cell. of Gastroenterology.